Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tagarafdeg

😃Good
Catalog No. T77972Cas No. 2882165-79-7
Alias CFT-1946, CFT1946, CFT 1946

Tagarafdeg (CFT1946) is an orally available PROTAC degradator targeting mutant BRAF, capable of degrading BRAF V600E (Class I), G469A (Class II), G466V (type III) mutations, and the p61-BRAF V600E splice variant. It exhibits favourable selectivity within the proteome, including for wild-type BRAF and CRAF, and inhibits tumour cell proliferation.

Tagarafdeg

Tagarafdeg

😃Good
Catalog No. T77972Alias CFT-1946, CFT1946, CFT 1946Cas No. 2882165-79-7
Tagarafdeg (CFT1946) is an orally available PROTAC degradator targeting mutant BRAF, capable of degrading BRAF V600E (Class I), G469A (Class II), G466V (type III) mutations, and the p61-BRAF V600E splice variant. It exhibits favourable selectivity within the proteome, including for wild-type BRAF and CRAF, and inhibits tumour cell proliferation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$479InquiryInquiry
5 mg$1,880InquiryInquiry
10 mg$2,570InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tagarafdeg (CFT1946) is an orally available PROTAC degradator targeting mutant BRAF, capable of degrading BRAF V600E (Class I), G469A (Class II), G466V (type III) mutations, and the p61-BRAF V600E splice variant. It exhibits favourable selectivity within the proteome, including for wild-type BRAF and CRAF, and inhibits tumour cell proliferation.
In vitro
In A375 cells, Tagarafdeg (CFT1946) effectively degraded BRAFV600E (Emax = 26%; DC50 = 14 nM, 24 hours) and inhibited ERK phosphorylation (IC50 = 11 nM, 24 hours) and cell growth (GI50 = 94 nM, 96 hours), while having no effect on the mutant KRAS-driven cell line HCT116. [2]
In vivo
METHODS: Tagarafdeg (10 mg/kg, orally, twice daily) was used to treat A375 xenograft mice, and tumor growth in the mice was observed.
RESULTS: Tagarafdeg resulted in deeper tumor regression. [2]
SynonymsCFT-1946, CFT1946, CFT 1946
Chemical Properties
Molecular Weight958
FormulaC45H49F2N11O9S
Cas No.2882165-79-7
SmilesCN1C=2C(C(=N1)N3C(=O)NC(=O)CC3)=CC(F)=C(C2)N4CCC(CC(=O)N5CCC6(CC5)C[C@H](CO6)N7C(=O)C=8C(N=C7)=CC=C(OC9=C(C#N)C(NS(N(CC)C)(=O)=O)=CC=C9F)C8)(O)CC4
ColorWhite
AppearanceSolid
Storage & Solubility Information
Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (83.51 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.0438 mL5.2192 mL10.4384 mL52.1921 mL
5 mM0.2088 mL1.0438 mL2.0877 mL10.4384 mL
10 mM0.1044 mL0.5219 mL1.0438 mL5.2192 mL
20 mM0.0522 mL0.2610 mL0.5219 mL2.6096 mL
50 mM0.0209 mL0.1044 mL0.2088 mL1.0438 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tagarafdeg | purchase Tagarafdeg | Tagarafdeg cost | order Tagarafdeg | Tagarafdeg chemical structure | Tagarafdeg in vivo | Tagarafdeg in vitro | Tagarafdeg formula | Tagarafdeg molecular weight